The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1120
December 10, 2001
View Complete Issue         Table of Contents 2019 
Update on Glucosamine For Osteoarthritis
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Update on Glucosamine For Osteoarthritis
December 10, 2001 (Issue: 1120)
Since the last Medical Letter article on glucosamine for osteoarthritis (vol.39, page 91, September 26, 1997), more data have become available. Glucosamine is available in US pharmacies and health food stores as sulfate, hydrochloride or n-acetyl...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Update on Glucosamine For Osteoarthritis
Article code: 1120c
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.